P-85 Metabolic syndrome identifies chronic kidney disease in Chinese patients with Type 2 diabetes — a prospective study

2008 ◽  
Vol 79 ◽  
pp. S86 ◽  
Author(s):  
A. Luk ◽  
R.C.W. Ma ◽  
W.Y. So ◽  
A.P.S. Kong ◽  
X. Yang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Prospective Study ◽  
Chinese Patients ◽  
A Prospective Study

Erlotinib appears to produce prolonged remission of insulin-requiring type 2 diabetes associated with metabolic syndrome and chronic kidney disease

2012 ◽  
Vol 12 (2) ◽  
pp. 87-90 ◽  
Author(s):  
Marvin B. Brooks
Keyword(s):  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Oral Medication ◽  
Oral Glucose ◽  
Epidermal Growth

Patients with metabolic syndrome are at higher risk for type 2 diabetes and for chronic kidney disease. Metformin is the oral medication of choice for the treatment of type 2 diabetes in the absence of chronic kidney disease. There is a need for another oral glucose lowering agent for use in metabolic syndrome with type 2 diabetes and chronic kidney disease. We submit the first report of erlotinib, a once-daily oral medication for the treatment of non-small-cell lung cancer associated with specific genetic mutations, appearing to eliminate the need for insulin in insulin-requiring type 2 diabetes associated with metabolic syndrome and chronic kidney disease. The mechanism by which erlotinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor may improve glycaemic control is unknown. Potential possibilities are explored.

Serum Uric Acid, the Metabolic Syndrome, and the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes

2014 ◽  
Vol 12 (2) ◽  
pp. 102-109 ◽  
Author(s):  
Sara Sheikhbahaei ◽  
Akbar Fotouhi ◽  
Nima Hafezi-Nejad ◽  
Manouchehr Nakhjavani ◽  
Alireza Esteghamati
Keyword(s):  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Uric Acid ◽  
Kidney Disease ◽  
Serum Uric Acid ◽  
The Metabolic Syndrome

scholarly journals The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0134981 ◽  
Author(s):  
Andrea O. Y. Luk ◽  
Wai-Chi Fu ◽  
Xue Li ◽  
Risa Ozaki ◽  
Harriet H. Y. Chung ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Clinical Utility ◽  
Chinese Patients

scholarly journals Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 Diabetes

Diabetes Care ◽  
2006 ◽  
Vol 29 (11) ◽  
pp. 2439-2444 ◽  
Author(s):  
P. C.Y. Tong ◽  
A. P.S. Kong ◽  
W.-Y. So ◽  
M. H.L. Ng ◽  
X. Yang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cardiovascular Outcomes ◽  
Chinese Patients
Sign in / Sign up

Export Citation Format

Share Document